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BACKGROUND: Experts suggest an individualized ap-
proach to colon cancer screening to take into account
variation in older adults’ life expectancies and potential
to benefit from screening. However, little is known
about how physicians make decisions about colon
cancer screening in adults age 75 and older.
OBJECTIVE: To understand whether physicians em-
ploy individualized decision making for colon cancer
screening in older adults, and, if so, to determine the
individual factors they believed were important to
consider in making such decisions.
DESIGN: Qualitative research using focus groups and
individual interviews
PARTICIPANTS: Fifteen primary care physicians prac-
ticing in community settings participated in three focus
groups and two interviews.
APPROACH: We used two clinical vignettes of 78-year-
old women in fair and poor health states to stimulate
discussions about clinical decision making for CRC
screening in older adults.
RESULTS: Physicians considered a wide range of
factors, including clinical factors, such as age, life
expectancy, co-morbidities, and functional status, as
well as individual factors, such as personality, previous
screening behavior, family support, and the relation-
ship with the patient. Physicians reported difficulty with
these decisions because of their complexity and be-
cause they involve life expectancy estimates. Their
approach and discussion with patients seemed to be
dependent on the degree of certainty they perceived
regarding their clinical assessment as to whether the
patient had the potential to benefit from screening.
CONCLUSIONS: Colorectal cancer screening decision
making is complex. Physicians reported using a range
of clinical and individual factors to decide about
colorectal cancer screening in older adults.
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BACKGROUND
A blanket recommendation in favor of colon cancer screening
is not appropriate for elderly patients. Instead, experts suggest
an individualized approach to take into account variation in
older adults’ life expectancies and potential to benefit from
screening1–4. The mortality benefit from screening may be
delayed up to 10 years because colon cancers are generally
slow growing5. Yet, the potential risks of undergoing colono-
scopy are immediate and significant; they include bleeding
severe enough to require hospital admission, bowel perfora-
tion, and even death6. The challenge physicians face is
deciding how best to weigh the immediate risks of screening
against the likelihood of benefiting from screening, given the
life expectancy of an older individual.
Most of the studies evaluating screening in older adults
have been cross-sectional, observational assessments of the
association between hypothesized factors affecting the decision
and actual screening behavior7–10. These studies show incon-
sistent associations among health status, age, and screening
behavior. The cause of these inconsistencies is unclear, but
may be due to the complex process required for individualized
decision making. Few studies have directly evaluated physi-
cians’ decision making to determine whether physicians
consider health status and life expectancy,11–13 and none to
our knowledge have used qualitative methods to explore the
process physicians use to decide whether screening older
adults for colon cancer would be beneficial.
Our aims for this study were to learn whether physicians
employ individualized decisionmaking for colon cancer screening
in older adults and to explore factors they believe are important to
make these decisions. In addition, we were interested in learning
whether physicians perceive this decision-making process to be
difficult. Finally, we were interested in knowing more about how
physicians perceive the role of older patients in the decision-
making process and their approaches to discussions with elderly
patients in regards to colon cancer screening.
METHODS
Interview Guide Development
We designed our interview guide based on a conceptual
model of decision making for colon cancer screening in older
adults that we developed based on existing literature
regarding cancer screening in older adults2–4 and our clinical
experience.
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Weused our conceptualmodel to develop questions related to
the primary constructs of (1) the decision-making process, (2)
difficulty with decision making, (3) the patient role in the
decision-making process, and (4) patient provider communica-
tion about screening, particularly when discussions focused on
stopping screening. Our interview guide is provided in Table 1.
We used two clinical vignettes of 78-year-old women in fair
and poor states of health to stimulate and focus the discussion
on clinical decision making in older adults. These vignettes
were developed and refined in an iterative process with five
health services researchers and seven practicing physicians
who agreed that they were representative of fair and poor
health states. In a previous study, resident physicians were
able to accurately estimate life expectancy from these scenar-
ios when compared to life table estimates, suggesting that
these vignettes represent believable patient scenarios14.
Recruitment
To identify physician participants, we recruited primary care
physicians in practices in North Carolina who also precept first
and second year medical students in the Introduction to
Clinical Medicine Course through the University of North
Carolina School of Medicine. We chose to recruit from these
physicians for two reasons: (1) it assured a level of quality in
decision making that had been vetted by interactions with the
course director and students, and (2) their ties to the course
and course director provided an entrée for their recruitment.
We obtained a list of Family Medicine and General Internal
Medicine preceptors for the course from the course director to
serve as contacts for the practices. Due to resource con-
straints, we limited our recruitment to practices within a
2-h drive of our research office. From this list, we identified
practices that had four or more providers either by calling the
practices to ask them or searching the internet to identify the
number of providers in the practice. We sent an introductory
letter to the practice from the course director to the contact
physician at these practices, and one of the MD investigators
(CL) followed up with a telephone call. If a full practice was
unable to participate in a focus group or had only one or two
eligible physicians interested in participating, we invited those
individual physicians with interest to participate in individual
interviews.
Focus Group/Interview Session
Focus groups or interviews were held in locations convenient
to the participants, most often in their offices, but one was in a
private room at a local restaurant. All focus groups and
interviews were conducted by the same experienced lead
moderator (JG) and physician co-moderator (CL). We obtained
informed consent from each participant at the beginning of
each session, and participants also completed a brief survey
assessing basic demographic information, medical training,
and number of years in practice. Each physician participant
was provided with $100.00 cash for participating, in addition
to a meal. Our study was approved by the University of North
Carolina Office of Human Research Ethics.
After introductions of the study staff, we defined the
purpose of the session for participants with this opening
statement “We have asked you to participate because you are
a primary care physician who sees patients ages 75 and older.
As you know, colon cancer is an important cause of morbidity
and mortality for older patients. Because colon cancer screen-
ing in older patients is an area of clinical uncertainty, we are
asking for your input. The information you provide will help us
better understand how physicians approach this issue in
clinical practice.”
We opened each focus group and interview with an “ice
breaker” question to help participants begin to consider their
approaches to colon cancer screening in general, by asking
them to think about things that made it easier or harder for
people to get screened for colon cancer. In addition to serving
as an ice breaker, the purpose of this exercise was to discuss
potential logistical barriers to screening first, so that, for the
rest of the session, participants could focus primarily on their
decision-making processes. After this exercise, we told the
participants to assume that for these elderly patients, all
system and individual level barriers had been addressed, that
those who wanted to be screened would be able to do so.
We then presented the first clinical vignette, a 78-year-old
woman in fair health, as a means to stimulate discussion of
Table 1. Focus Group and Interview Questions Related to the Construct from the Conceptual Model
Construct Key question Probes
Decision-making process ● What are your thoughts about colon
cancer screening in Mrs. Perry?
● How would you go about deciding whether
or not screening Mrs. Perry for colon cancer
would be helpful to her?
● What factors would you consider in
deciding about CRC screening in this
patient or others like her?
● How do you assess if she could benefit from
being screened?
● How do you weigh these factors to make a
decision about screening?
Difficulty with decision making ● Please describe the difficulty, if
any, you faced when making colon
cancer screening decisions in older adults.
Patient role in decision making ● What do you see as the patient’s role
in this decision?
● How would you incorporate the desires and
choices of the patient into the decision?
Physicians approach to patient ● How would you address colon cancer
screening with Mrs. Brandon?
● Under what circumstances would you not
discuss stopping screening with older patients
like Mrs. Brandon?
● Would you discuss colon cancer
screening with her?
● What do you see as Mrs. Brandon’s role in
the decision?
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clinical decision making for colon cancer screening in older
adults (Table 2). The physicians were asked about the decision-
making process that they would use for this patient and
similar older patients. In addition, we asked whether they
experienced any difficulties with making decisions about
screening with patients like the one presented in the vignette.
Participants were also asked how they perceived the patient role
in the decision-making process. We then presented the second
clinical vignette, a woman, aged 78 years, who was in poor
health. As with the first vignette, physicians were asked about
the decision-making process they would use for this scenario,
the role of the patient in the decision-making process, and if
(and how) they would approach screening for this patient. Each
session closed with an opportunity for the physicians to
reiterate earlier statements, provide clarifications, or share
additional thoughts they believed relevant to the topic.
Thirteen physicians participated in three focus groups (two
sessions with five participants and one session with four
participants). These sessions lasted from 55 to 90 min. Two
additional physicians were interviewed in person because they
were unable to participate in focus groups with the other
members of their practice. The individual interviews lasted
approximately 20 to 25 min. In general, the content of the
discussions was similar between the focus groups and the
individual interviews. However, the focus groups tended to
generate more informal discussions about particular patients,
which led other participants to provide additional patient
anecdotes. This interchange provided rich information that
helped to clarify the decision-making process.
DATA ANALYSES
The data were transcribed by a professional transcriptionist
and analyzed by two of the authors (CL and JG), using ATLAS.
ti15. Each transcript was content analyzed to identify recurring
themes, including of factors related to whether and when to
screen older adults for colon cancer. The codebook was
developed using an iterative process, revising if needed after
each focus group or interview. After independently coding the
first interview transcript, the two coders met to further refine
the codebook with new codes based on unanticipated topics
that emerged, and consensus was obtained for each code’s
definition. The iterative process also allowed the interview
guide to be modified to explore new areas of inquiry. As the
analysis progressed, over-arching themes emerged. Differences
in coding for sections of text were reviewed and resolved
through discussion and consensus. Data collection was con-
cluded when no new themes were identified and saturation
had been reached16–18.
RESULTS
Our participants included five women and ten men with an
average age of 43 and 11 years in practice, respectively; nine of
the participants were internal medicine physicians, and six
were family medicine physicians.
Overview of the Decision-making Process
We found that physicians considered a wide range of factors in
making decisions about colon cancer screening in older adults.
However, the interplay of these factors in the decision-making
process depended on the physician’s initial clinical assessment
about whether they thought the patient could benefit from
screening. They reported difficulty with these decisions be-
cause of the complexity and because they involve life expec-
tancy estimates. Physicians made it clear that their decision
making was limited by the uncertainty inherent in estimating
whether a patient could potentially benefit from screening.
Consequently, the decision-making process and their percep-
tion of the role of patients in the decision appeared to be
influenced by the degree of uncertainty they felt about their
initial clinical assessment of potential benefit from screening.
FACTORS IMPORTANT TO DECISION MAKING
Four primary categories of factors emerged from the discus-
sion of the decision-making processes they would use to decide
about screening patients in each clinical vignette as well as
patients similar to those in the vignettes. These four groups of
factors were clinical factors, individual patient factors, the
likelihood of pursuing treatment if cancer is found, and how to
weigh these factors to make a decision.
Clinical Factors
Physicians highlighted life expectancy, age, and functional
status as important clinical factors in their decision making.
In general, physicians perceived that the potential benefits of
screening were delayed and that a life expectancy of 5 to
10 years was necessary to reap these benefits. One participant
expressed their views regarding life expectancy with the
following comments:
The whole thing with colon cancer screening is that
you’re trying to find something before and make a
Table 2. Clinical Vignettes
Mrs. Perry—fair health vignette
● 78-year-old woman
● Moderate COPD, well-controlled hypertension
● Severe osteoarthritis in both knees, limits her ability
to walk outside her house
● Experiences shortness of breath with activities
only when she does not take her inhalers
● Lives alone; has no trouble dressing or bathing
herself; prepares her own meals; takes care of her
finances without problems
● Her son drives her to the grocery store, but she is
able to shop for groceries independently
● Her last mammogram was several years ago, she is not certain
exactly when
● She has never been screened for colon cancer
Mrs. Brandon—poor health vignette
● 78-year-old woman
● Severe heart failure due to coronary heart disease
● Shortness of breath with exertion despite optimal medical
management
● Re-vascularized 10 years ago, but is not a candidate for repeat CABG
● Able to perform her ADLs independently, but must
perform them slowly due to shortness of breath
● Life expectancy according to life tables is most likely less than 2 years
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difference 5-10 years down the road. If you don’t have 5,
10 years then what’s the point?
Physicians also indicated the interdependence of age and
co-morbidities in their decision making as noted by the
following comment from a participant:
I mean, to me, you could be 75, but you can have 0 life
expectancy because of co-morbidities or you could be 85
and have a 10-year life expectancy.
When discussing their decision-making process, the physi-
cians emphasized the importance of life expectancy and used
co-morbidities, age, and functional status to estimate whether
or not individual patients would live long enough to have the
potential to benefit from screening. For patients in good health,
the physician reported using average life expectancies of
persons at that age as a basis for their decision-making process.
When discussing patients in poorer health, the severity of the
health conditions and the patient’s functional status became
the focus of the discussion. The underlying premise for the
decision-making process for all patients was whether undergo-
ing screening could extend the patient’s life or would subject the
patient to potential harms without a chance of benefiting.
Individual Patient Characteristics
In addition to clinical factors, physicians also considered
patient characteristics. The range of individual patient char-
acteristics that physicians reported as influencing their deci-
sion making was extremely wide. Factors, such as the living
situation of the patient and their family support, the person-
ality of the patient, their previous screening behavior, and the
duration and type of relationship they have with the patient
played a part in their decision making.
For example, physicians noted that if a patient had been
aggressive about screening in the past or their personality
tended towards being proactive about screening, those individ-
ual factors would be included in the decision-making process:
I mean, if she came in saying I want to do everything I
possibly can to stay alive because I’m responsible, but if
she was already seeming like, quality of life is not that
great and look at her cardiovascular risk factors.
They not only considered factors related to the patient but
also to their family members. One aspect was family support.
I might look at also their family support. Like if they have
a husband who’s going to help with the prep or if she
lives alone.
Another aspect was the opinions of the family members
about screening.
But, family and even their kids [are important]. I get
older folks where their sons and daughters are the ones
telling them they need a colonoscopy more than they’re
wanting to have one. I’m not saying that’s something that
makes sense, but it’s something that gets considered.
In describing their decision-making process, clinical factors
seemed to take precedence over individual factors. Individual
factors came into play when they felt some degree of uncer-
tainty about their initial clinical assessment of benefit, and
then, specific individual factors could sway the decision
making. For example, if a patient has a family member
available to help them with the preparation procedures for
their colonoscopy, then the physician would be more inclined
to recommend in favor of screening than if no family member
was available to help.
Weighing Potential Benefits and Harms
The physicians also described a process of weighing the
potential benefits against the potential harms of putting an
older patient through screening, particularly a colonoscopy.
Although physicians reported a number of factors they
considered in the decision-making process, it was difficult for
them to articulate how they put all these factors together to
make an overall determination of net benefit. Instead of
providing an explanation, some participants reported that the
decision of whether or when to screen was based on more of
gestalt than an actual process of weighing all of the factors.
They seemed to base this on a feeling of knowing the patient
and their medical problems and emphasized the importance of
having a long-term relationship with the patient.
You know my gut feeling about this person is, you know,
they wouldn’t benefit from it.
The major concern in weighing the risks and benefits
seemed to be the concern about causing harm when there
was no chance that a patient could benefit and also about
causing distress from a colonoscopy.
I mean, if someone is 80 and you recommend a colono-
scopy and then their bowel got [perforated]. What was I
thinking, 80 years old, doing this colonoscopy?
Likelihood of Pursuing Cancer Treatment
Physicians reported that they took into consideration what they
would do with the information they got from a screening test
andwhether it would change theirmanagement of the patient in
the future. If they were unlikely to pursue treatment for the
patient, then they were less likely to recommend screening:
But she’s not a candidate for any kind of surgery and
what’s the benefit of removing a polyp, you know?
Physician Difficulty with Decision Making
Some physicians reported that the decision-making process of
whether to screen their older patients for colon cancer was
difficult for them. The difficulty seemed to stem from two
sources. First, the sheer number of factors that they had to
weigh in the decision-making process.
Compared to younger adults, one participant reported:
That there are a lot more variations from one person to
another. A lot more to consider. It’s not just a matter of
how old they are and what’s their family history
Another physician provided an example of when other
clinical issues take precedence over colon cancer screening.
I mean there are some people who come in and when you
watch them walk down the hall and they’re 300 pounds
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and they’ve got the O2 strapped to their side and they’ve
got diabetic foot ulcers and everything that you know
and they’re 68 years old. You just know they’re not going
to make it, and colon cancer is the last of their thought
process and putting them through something like that is
just, I just don’t think it’s a reasonable thing,
The other source of difficulty with the decision-making
process was the underlying uncertainty of whether or not a
patient would live long enough to benefit from screening.
You get into the gray area because nobody knows. We
don’t have a crystal ball. We don’t know how long
somebody is going to live for.
Physician Perception of the Patient and Physician
Role in the Decision-Making Process
While discussing the fair health vignette, we asked the
physicians about the role of the patient in the decision-making
process. In this context the physician participants reported a
highly autonomous role for the patient in the decision-making
process as highlighted by the comments below.
I mean it’s totally their decision. My role is just to remind
them and to advise them.
Many participants emphasized that the physician’s role was
to provide information to help the patient understand the
decision.
Our obligation is to give them the data. Give it to them in
a way they can understand. If they don’t have any
problems understanding why we’re talking about this
and then let them make the decision themselves. It’s not
our decision to make. It’s theirs.
Approach to Elderly Patients
When we asked how they would approach the patient in the
fair health vignette, the general approach was consistent with
shared decision making.
I would always, at least, talk about it and offer it if their
life expectancy could be 10 years.
The first question I ask is “are you interested in doing this?”
However, when we asked how the physicians would approach
the patient represented by the poor health vignette, physicians
differed in their opinions about whether the topic of screening
should bebroughtup at all. Some indicated that theywould bring
up the topic of screening themselves, but others stated that they
would discuss it only if the patient asked about it.
Bringing it up is the reasonable thing, but then you have to
be very, very honest with them and you have to say look it
here’s a situation what are you going to really do if they tell
you there’s there and we have to do something about it? Do
you really want to know that?
Some pointed out that they would be thinking about other
issues in a patient with that many health issues.
[I] Wouldn’t even think about it.
Summary of Physicians’ Decision-Making
Processes for Colon Cancer Screening in Elderly
Patients
When describing their decision-making process, physicians
first made a clinical assessment of whether they thought the
patient would likely benefit from screening. Based on this
assessment and their certainty with this assessment, they
then considered individual factors. These factors would either
support their clinical assessment or sway them in the opposite
direction. Their flexibility in the decision-making process and
their approach and discussion with patients seemed to be
dependent on their level of certainty about their initial clinical
assessment.
DISCUSSION
Physicians that participated in our study generally described a
decision-making process consistent with an individualized
decision-making approach as described by Walter and Cov-
insky and others2,4. They considered the potential benefits of
screening in the context of the patient’s life expectancy, as well
as the potential harms given the patient’s health state and
functional status. Physicians reported difficulty with these
types of decisions, commenting on the uncertainty involved in
estimating life expectancy and worries about harms. Physi-
cians endorsed a shared or informed decision-making model
when asked directly about the patient’s role in the decision.
However, the approach seemed to depend on whether the
physician thought the patient could potentially benefit from
screening. When discussing their approach to the patient in
fair health and those similar to her, physicians reported having
discussions and considering the patient’s preferences. For the
patient in poor health and those similar to her, most partici-
pants described a more paternalistic approach, perhaps
because they felt more confident that the patient was unlikely
to benefit from the procedure.
Our study highlights the sheer complexity of the decision-
making process in deciding whether or not to recommend
colon cancer screening for elderly patients. This complexity
could lead to inconsistent decisions among physicians. Lack of
knowledge about the delay in benefit could also lead to over
screening those least likely to benefit. We found that physi-
cians appropriately considered the delay in benefit in the
context of the patient’s estimated life expectancy, citing 5 to
10 years as the time necessary to benefit.
The patient’s role in the decision-making process described
by the physicians was complex. On one hand, physicians
generally endorsed the idea that the patient made the ultimate
decision about screening. This belief was supported in their
discussions about how they would approach the patient in fair
health. However, in the context of a patient who most likely
would not benefit from screening (poor health state vignette),
physicians endorsed a much more directive approach. This
behavior seems to contradict their previous assertions that the
patient should make the decision. Perhaps physicians perceive
that patients should participate in the decision only if they
believe there is a potential to benefit. This thinking would be
consistent with a major tenet of medicine of doing no harm.
There are several limitations to consider when interpreting
our findings. First, our findings are self-reported in response to
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clinical vignettes and may not reflect what physicians actually
do in clinical practice. Although clinical vignettes have been
shown to represent physicians' real practices adequately19,20,
some aspects of the decision making for colon cancer
screening of older adults appeared to be influenced by the
relationships physicians have with their patients. This would
not be captured with our vignettes. Furthermore, this study
addressed only the physician perspective on the decision-
making process. Patients’ perspectives are important in
obtaining a more complete understanding of the decision-
making process, and we plan in future studies to include
their views. Additionally, we resorted to individual interviews
when we were unable to recruit these physicians’ practices
for focus groups. Finally, as with all qualitative work, the
sampling was purposeful so the findings may not be
generalizable.
Physicians described an individualized decision-making
process based on their clinical assessment and other individ-
ual patient factors. Physicians considered a wide range of
factors, including clinical factors, such as age, life expectancy,
co-morbidities, and functional status as well as individual
factors, such as personality, previous screening behavior,
family support, and the relationship with the patient. Physi-
cians reported difficulty with these decisions because of their
complexity and because they involve life expectancy estimates.
Their approach and discussion with patients seemed to be
dependent on the degree of certainty they perceived regarding
their clinical assessment as to whether the patient had the
potential to benefit from colon cancer screening. Further
research is needed to examine whether variation in these
clinical assessments could explain the inconsistencies seen in
observational studies examining health state and cancer
screening behavior.
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